Anti-Inhibitor Coagulant Baxter - Biotech, Pharma and Life Science Channel
PubMed Articles
Study of critical role of c-Met and its inhibitor SU11274 in colorectal carcinoma.
c-Met plays an important role in colorectal tumorigenesis and disease progression and thus is believed to be an attractive inhibitory target for receptor molecular therapeutic. SU11274 was identified...
TL-118-anti-angiogenic treatment in pancreatic cancer: a case report.
Pancreatic cancer is one of the most aggressive malignant tumors. In recent years, little progress has been made in understanding and treatment of the disease. The two most commonly used chemotherapy...
Pheochromocytoma is a rare but potentially lethal chromaffin cell tumor with currently no effective treatment. Peptide hormone receptors are frequently overexpressed on endocrine tumor cells and can b...
This study used primary socialization theory and a focus theory of normative conduct to examine whether anti-substance-use norms mediated targeted parent-child communication against substance (alcohol...
Subtle "supramolecular buttressing effects" in Cucurbit7uril/guest assemblies.
Biphenyl derivatives bearing a dimethylsulfonium group at position 3 and three different substituents at position 4 (H, F and CH3) have been prepared as probes to test the validity of the "supramolecu...
Chiral N-heterocyclic carbenes (NHCs) promote the asymmetric formal [4 + 2] cycloaddition of alkylarylketenes with β,γ-unsaturated α-ketocarboxylic esters and amides. Divergent diastereoselectivity...
The research on fast screening methods for antibodies against zoonotic pathogens in slaughter animals is important for food safety in farming and meat-processing industries. As a proof-of-concept stud...
JAK/STAT signalling is essential for anti-viral immunity, making IFN-α an obvious anti-viral therapeutic. However, many HCV+ patients fail treatment, indicating that the virus blocks successful IFN-Î...
A crucial role for Lyn in TIMP-1 erythroid cell survival signalling pathway.
TIMP-1, a well-known MMP inhibitor, displays other biological activities such as cell survival, proliferation and differentiation in hematopoietic cells. In this report, we investigated the role of th...
Calpain Inhibition Prevents Ethanol-Induced Alterations in Spinal Motoneurons.
Long-term exposure of ethanol (EtOH) alters the structure and function in brain and spinal cord. The present study addresses the mechanisms of EtOH-induced damaging effects on spinal motoneurons in vi...
News Articles
Nichi-Iko Japan President: Joint Infliximab Phase III Trials With Sanofi In June 2013
Nichi-Iko Japan President Yuichi Tamura revealed that the company plans to start Phase III trials with the anti-rheumatic drug infliximab (Remicade) biosimilar in collaboration with Sanofi from June.
Baxter to launch HyQvia in Germany first
Baxter is to introduce HyQvia, a replacement therapy for adult patients with primary and secondary immunodeficiencies, in select countries in the coming weeks with further EU launches scheduled for 2...
Pyratine®’s Acclaimed Healing Ointment Provides Powerful Burn Relief
PyratineXR® Intensive Anti-Redness & Healing Ointment Receives Accolades from Users (PRWEB) May 22, 2013 Pyratine®LLC, the makers of the widely acclaimed line of skin care for rosacea,...
Arizona Teens Combat Tobacco Use With Community Pledges and 'No-smoking' Art
PHOENIX, May 22, 2013 /PRNewswire/ -- Arizona teens have united this month in the global fight to end tobacco use. As members of the statewide anti-tobacco youth coalition STAND (Students Taking a New...
Baxter and Halozyme's HyQvia approved in European Union
USA-based Baxter International (NYSE: BAX) and Halozyme Therapeutics (Nasdaq: HALO) say that the European Commission has granted Baxter marketing authorization in all European Union member states for...
Molecular roots of cocaine addiction in brain uncovered: Promising new anti-addiction drug revealed
Researchers have unraveled the molecular foundations of cocaine’s effects on the brain, and identified a compound that blocks cravings for the drug in cocaine-addicted mice. The compound, already pr...
Mari's to Offer New Treatment from Europe
Mari's Skin Care is the first to offer Meta Therapy in the state of Texas. Dallas, TX (PRWEB) May 22, 2013 Mari’s Skin Care, a peaceful sanctuary for skin rejuvenation and nourishment in Dallas...
Antidepressant Escitalopram Helps Heart Problem Caused By Stress
Researchers at Duke Medicine have revealed that a commonly prescribed antidepressant - escitalopram (Lexapro) - could be used to treat a heart condition caused by stress among people suffering from st...
US Organic Group develops over-the-counter organic anti-itch ointment
US Organic Group has developed an over-the-counter organic anti-itch ointment, Anti Itchbalm, for itchy skin.
Europe approves Baxter/Halozyme's HyQvia
Europe approves Baxter/Halozyme's HyQvia
Events
Global Anti-Corruption and Corporate Compliance for Pharma
Delivering Effective Third Party Management and Best Practice Compliance
Companies
Puma Biotechnology, Inc. is a development stage biopharmaceutical company that acquires and develops innovative products for the treatment of various forms of cancer. The Company...
Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis...
Opsona is a leading immunology drug development company, focused on novel therapeutic approaches to key targets of the innate immune system associated with a wide range of majo...
Enanta Phatmaceuticals ARE A RESEARCH AND DEVELOPMENT-FOCUSED BIOTECHNOLOGY COMPANY that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs in t...
BioRelix, Inc, is a drug discovery and development company focused on identifying new anti-infective drug treatments. BioRelix is building a portfolio of anti-infective products b...
Founded in 1989, Integrity Engineering, Inc. is an engineering firm focused on developing new technologies and providing superior engineering design, analysis and educational serv...
Superfocus glasses were invented by Dr. Stephen Kurtin, a successful inventor with more than 30 patents to his name. Recognizing that multi-focals, progressives or carrying multip...
Baxter International Inc. and Takeda Pharmaceutical Company Limited
Baxter International Inc. (NYSE: BAX), through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune d...
Clear Catheter Systems is a Bend, Oregon based medical device company developing an anti-clogging platform of surgical drainage devices. Its lead product is the PleuraFlow Cathete...
Auspex Pharmaceuticals is a privately held biopharmaceutical company located in La Jolla, California. The company is a pioneer in the use of deuterium in medicinal chemistry, and...
Clinical Trials
The investigators hypothesize that a calcineurin inhibitor-free, steroid-free, co-stimulatory blockade-based immunosuppressive regimen, in combination with a GLP-1 agonist, will reduce the...
Pilot Study of Cetuximab and the Hedgehog Inhibitor IPI-926 in Recurrent Head and Neck Cancer
This study will evaluate the clinical activity of the combination of ipilimumab (IPI) -926 in combination with cetuximab in patients with advanced head and neck cancer.
This Post Marketing Surveillance study will be performed as an open-label, prospective, non-interventional, uncontrolled study in Human immunodeficit Virus-1 (HIV-1) infected patients. Dat...
BAY43-9006 - Phase II in Advanced Breast Cancer
The purpose of this study is to evaluate the anti-cancer activity and safety of BAY43-9006 (Sorafenib) in patients, who suffer from an advanced breast tumour, which has spread to other org...
Evaluation of GW406381 in Treating Adults With Osteoarthritis Of The Knee
This study was designed to evaluate the effectiveness of GW406381 (a COX-2 inhibitor) in treating the signs and symptoms of osteoarthritis of the knee.
The purpose of this investigation is to collect following data in patients given Nexium capsule (Nexium) for long term in usual-post-marketing therapy to prevention of recurrence of gastri...
The primary purpose of this study is to assess whether at least one dose of LY2216684 (12 mg or 18 mg once daily) is superior to placebo once daily in the adjunctive treatment of patients...
Antithrombotic Triple Therapy in Humans
Background:The acute coronary syndrome (ACS) is a complication of coronary artery disease (CAD) and associated with increased mortality. Dual antiplatelet therapy of acetylsalicylic acid (...
Can Tadalafil Maintain Erectile Function In Patients Treated With Radiotherapy For Prostate Cancer?
Because of the high incidence of post-radiation erectile dysfunction (ED), up to 72% after external-beam radiotherapy, this patient category represents a most difficult therapeutic challen...
The objective of the study is to identify and validate predictive markers of infliximab responsiveness in RA patients by 2 approaches: i) measuring biochemical, immunological and bone mark...
Videos
Heparin
http://www.heparinrecall.info If you've been hurt by heparin, you may be entitled to a cash settlement. Health officials in the U.S. appear to be at loggerhe...
Medical and Biotech [MESH] Definitions
Anti-retroviral Agents
Agents used to treat RETROVIRIDAE INFECTIONS.
Immunoprecipitation
The aggregation of soluble ANTIGENS with ANTIBODIES, alone or with antibody binding factors such as ANTI-ANTIBODIES or STAPHYLOCOCCAL PROTEIN A, into complexes large enough to fall out of solution.
Phosphatidylethanolamine Binding Protein
A ubiquitously found basic protein that binds to phosphatidylethanolamine and NUCLEOTIDES. It is an endogenous inhibitor of RAF KINASES and may play a role in regulating SIGNAL TRANSDUCTION. Phosphatidylethanolamine-binding protein is the precursor of hippocampal cholinergic neurostimulating peptide, which is cleaved from the N-terminal region of the protein.
Complement C1 Inhibitor Protein
An endogenous 105-kDa plasma glycoprotein produced primarily by the LIVER and MONOCYTES. It inhibits a broad spectrum of proteases, including the COMPLEMENT C1R and the COMPLEMENT C1S proteases of the CLASSICAL COMPLEMENT PATHWAY, and the MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES. C1-INH-deficient individuals suffer from HEREDITARY ANGIOEDEMA TYPES I AND II.
Cyclin-dependent Kinase Inhibitor Proteins
A group of cell cycle proteins that negatively regulate the activity of CYCLIN/CYCLIN-DEPENDENT KINASE complexes. They inhibit CELL CYCLE progression and help control CELL PROLIFERATION following GENOTOXIC STRESS as well as during CELL DIFFERENTIATION.
